| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970231 | The Journal of Heart and Lung Transplantation | 2014 | 7 Pages |
Abstract
Our study shows that EVLP with high-dose, empirical anti-microbial agents in the perfusate is associated with an effective reduction in the microbial burden of the donor lung, a benefit that has not previously been demonstrated.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Anders MD, Danai M. MD, John D. PhD, Audrey MSc, Faruk FRCS, Tanveer FRCS, Katie E. MSc, Hannah R. PhD, Stephen C. DM, FRCS, Mahesh MD, FRCA, Paul A. FRCP, Kate FRCPath, Andrew J. PhD, FRCP, John H. FRCS,